Litcius/Paper detail

Management of immune checkpoint inhibitor in patients with cancer and pre-existing inflammatory bowel disease: Recommendations from the GETAID

Aurélien Amiot, David Laharie, Georgia Malamut, Mélanie Serrero, Florian Poullenot, Laurent Peyrin‐Biroulet, David Laharie, Arnaud Bourreille, Lucine Vuitton, Guillaume Bouguen, Véred Abitbol, Aurélien Amiot, Amélie Biron, Anne Bourrier, Ludovic Caillo, Mathurin Fuméry, Cyrielle Gilletta, Laurianne Plastaras, Mélanie Serrero, Marion Simon, Stéphanie Viennot, Philippe Seksik, Alain Attar, Anthony Buisson, Bénédicte Caron, Maëva Charkaoui, Jean‐Marc Gornet, Lucas Guillo, Catherine Le Berre, Edouard Louis, Georgia Malamut, Nicolas Mathieu, Maria Nachury, Stéphane Nancey, Stéphane Paul, Cathérine Reenaers, Xavier Tréton, Mathieu Uzzan, Pauline Wils

2022Digestive and Liver Disease12 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVedolizumabInflammatory bowel diseaseInfliximabColorectal cancerDiseaseInternal medicineColitisIntensive care medicineGrading (engineering)Ulcerative colitisCancerCivil engineeringEngineeringInflammatory Bowel DiseaseCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies